Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Patent
1980-11-24
1983-02-01
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
A61K 3314
Patent
active
043715222
ABSTRACT:
Discomfort in patients suffering from keratoconjunctivitis sicca is considerably relieved by instilling into the eyes of the afflicted patient a small amount of hypotonic solution suitably of a strength of between 25 and 75 percent isotonicity.
REFERENCES:
patent: 2547653 (1951-04-01), Minnis et al.
patent: 4039662 (1977-08-01), Hecht et al.
Chem. Abst. 63, 16,126(e-f), (1965), Grosz et al.
Contact Lenses Practice, 2nd Ed., Mandell, p. 513, (1977).
Int. Ophthal. Clin. 13, 145-153, (1973), Lemp, "Tear Substitute in the Treatment of Dry Eye".
Int. Ophthal. Clin. 13, 221-229, (1973), Lemp, "Artificial Tear Solution".
Handbook of Non-Prescription Drugs, 5th Ed., pp. 228-232 & 234-235, (1977).
Behr Omri M.
Robinson Douglas W.
LandOfFree
Keratoconjunctivitis sicca therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Keratoconjunctivitis sicca therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Keratoconjunctivitis sicca therapy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2407358